Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial

Elsevier, Vaccine, 41(33), p. 5437-5444, 2015

Journal article published in 2015 by Joon Young Song, Hee Jin Cheong, Jacob Lee, Heung Jeong Woo, Seong-Heon Wie, Jin-Soo Lee, Shin Woo Kim

, Ji Yun Noh, Won Suk Choi, Hun Kim, Kyung-Ho Kim, Woo Joo Kim

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by